0 Companies
Psychedelic Companies Researching Addiction
Psychedelics show strong potential for breaking addiction cycles, with psilocybin demonstrating significant results for alcohol use disorder and ibogaine attracting substantial research funding for opioid addiction treatment.
Trial pipeline:
1 Phase 1
1 total trialsNo companies found
No companies with tracked clinical trials for Addiction yet. Browse all companies